Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million

January 11, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

MONROVIA, Calif., Jan. 11, 2011 /- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for...

Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development

January 11, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding....

Decades-Long Medical Study Begins With Kickoff

January 10, 2011 10:35 pm | by San Diego Business Journal | News | Comments

The San Diego County component of the nation's largest long-term examination of children's health and development was launched Jan. 10.


Nationwide Children's Hospital awarded $11.5 million contract extension for biospecimen banking

January 10, 2011 8:33 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Nationwide Children's Hospital was awarded $11.5 million from the National Cancer Institute late last year to continue its role as one of two Biospecimen Core Resources for the Cancer Genome Atlas. Contract awards to Nationwide Children's could total up to...

ASU hosts child health forum in Washington

January 10, 2011 11:34 am | by Arizona State University | News | Comments

The College of Nursing & Health Innovation is joining Arizona State University to host a child health forum on Jan. 20 in Washington, more

Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL): Medication Use Error - Reports of Accidental Overdose

January 10, 2011 11:30 am | by U.S. Food & Drug Administration | News | Comments

Morphine sulfate oral solution ordered in milligrams (mg) were mistakenly interchanged for milliliters (mL) of the product.

Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification

January 10, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

NOVI, Mich., Jan. 10, 2011 /- Nopras Technologies, Inc., a globally recognized management consulting firm which specializes in services for organizations in the Pharmaceutical, Biotechnology, Medical Device and other FDA regulated industries announced on January 10th, 2011 that it has...

Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market

January 10, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 10, 2011 /- Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's...


Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games

January 10, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

WATERTOWN, Mass., Jan. 10, 2011 /- Drawing attention to its TemporalScanner™ Temporal Artery Thermometer during flu season, Exergen® Corporation is sponsoring "game-time temperature" for national radio broadcasts of NFL games and the upcoming College Bowl football games. The...

MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area

January 10, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

HAMILTON, N.J., Jan. 10, 2011 /- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system (CNS) disorders, announced the appointment of Christopher Randolph, PhD, ABPP-CN, to the new position of Vice President, Neurocognition.  Dr....

Cardinal Health to Release Second-Quarter Results on Feb. 3

January 10, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

DUBLIN, Ohio, Jan. 10, 2011 /- Cardinal Health plans to release second-quarter financial results for its fiscal 2011 on Thursday, Feb. 3, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a webcast and conference call for Feb. 3 at 8:30 a.m. EST to...

CoreLab Partners Launches Advanced Imaging Application

January 10, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 10, 2011 /- CoreLab Partners, Inc , the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine® . "We are pleased to announce the release of our proprietary...

Shionogi Inc. Announces Commercial Availability of KAPVAYâ„¢ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD

January 10, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

FLORHAM PARK, N.J., Jan. 10, 2011 /- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral...


Genetics Squared Changes Name To Everist Genomics

January 10, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Jan. 10, 2011 /- Genetics Squared, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara, Ph.D. as its...

Safety and Efficacy of OrbusNeich's Genousâ„¢ Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy

January 10, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Jan. 10, 2011 /- Data from patients who are considered high-risk due to underlying clinical conditions and who cannot be treated with drug eluting stents (DES) and the accompanying requirement of long-term dual antiplatelet therapy (DAPT) showed positive safety and short- and...

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

January 10, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Jan. 10, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease, a...

PositiveID Corporation Adds Olympian Gary Hall, Jr. as Advisor to Expand Its Diabetes Initiatives

January 10, 2011 4:33 am | by PositiveID | News | Comments

PositiveID Corporation Adds Olympian Gary Hall, Jr. as Advisor to Expand Its Diabetes Initiatives

Mindray Medical Meets 2010 Product Development Targets and Announces Strong 2011 Pipeline

January 10, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Jan 10, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2010 and its product pipeline for domestic and...

$200M Proton Therapy Centers to Deliver Cancer-Fighting Benefits

January 9, 2011 10:37 pm | by San Diego Business Journal | News | Comments

The battle for future proton therapy market share could shape up to be a highly competitive undertaking in the local health care economy if two projects come to fruition.

Sharp and Kaiser Are Putting Big Construction Plans Into Action

January 9, 2011 10:35 pm | by San Diego Business Journal | News | Comments

Construction projects planned by two local health care systems are promising to bring a major economic stimulus jolt to the San Diego region this year.

Engineering team invents lab-on-a-chip for fast, inexpensive blood tests

January 9, 2011 8:33 pm | by EurekAlert | News | Comments

(University of Rhode Island) While most blood tests require shipping a vial of blood to a laboratory for analysis and waiting several days for the results, a new device invented by a team of engineers and students at URI uses just a pinprick of blood in a portable device that provides...

TriReme Medical Announces Japanese Alliance

January 9, 2011 7:34 pm | by Bio-Medicine.Org | News | Comments

PLEASANTON Calif., SINGAPORE and TOKYO, Jan. 10, 2011 /- TriReme Medical, Inc. (TriReme) today announced that it has signed an exclusive distribution and sales agreement for TriReme's complete line of advanced peripheral and coronary balloon dilatation catheters with Century Medical, Inc....

Mayo researchers describe measles viral protein movement

January 9, 2011 9:32 am | by EurekAlert | News | Comments

(Mayo Clinic) Mayo Clinic researchers have shown that proteins on the surface of a cell twist a viral protein into position, allowing the virus to start infection and cause disease, all in a movement as graceful as a ballroom dance.

Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products

January 8, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., Jan. 8, 2011 /-- Bayer HealthCare Pharmaceuticals has become aware of a broad United States market recall of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names.  In the interest of patient safety, Bayer wants to...

Study: Many ICD Patients Don & #8217;t Meet the Guidelines

January 7, 2011 12:36 pm | by U.S. Food & Drug Administration | News | Comments

Nearly 25 percent of patients who receive implantable cardioverter-defibrillators (ICDs) for primary prevention don’t meet the evidence-based criteria, a new study published in the Journal of the American Medical Association (JAMA) says.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.